Review Board Recommends Bayer Halt Disparaging Glucose Monitor Ads
This article was originally published in The Gray Sheet
The National Advertising Review Board (NARB) recommends that Bayer stop claiming that its competitors' manually calibrated glucose meters are prone to inaccuracy and possibly dangerous
You may also be interested in...
ASTM International is proposing a new standard that will provide a cleaning agent formula for removing dried blood from stainless steel medical devices.
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma
The merger between Mylan and Pfizer’s Upjohn unit finally concluded on 16 November 2020, giving Viatris the go ahead for business. The newly-established company has announced receiving tentative approval for its 10mg pediatric dolutegravir tablets from the FDA under the PEPFAR program.